Mary Jane Thomassen

7.6k total citations
146 papers, 5.9k citations indexed

About

Mary Jane Thomassen is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Mary Jane Thomassen has authored 146 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Pulmonary and Respiratory Medicine, 44 papers in Physiology and 38 papers in Molecular Biology. Recurrent topics in Mary Jane Thomassen's work include Neonatal Respiratory Health Research (47 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers) and Cystic Fibrosis Research Advances (21 papers). Mary Jane Thomassen is often cited by papers focused on Neonatal Respiratory Health Research (47 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers) and Cystic Fibrosis Research Advances (21 papers). Mary Jane Thomassen collaborates with scholars based in United States, Myanmar and Egypt. Mary Jane Thomassen's co-authors include Mani S. Kavuru, Anagha Malur, Barbara P. Barna, Serpil C. Erzurum, Tracey L. Bonfield, Catherine Demko, Jeffrey D. Klinger, Raed A. Dweik, Suzy Comhair and Carol Farver and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Mary Jane Thomassen

143 papers receiving 5.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Jane Thomassen United States	46	3.4k	1.5k	1.4k	1.2k	920	146	5.9k
Hartmut Grasemann Canada	43	3.1k 0.9×	1.2k 0.8×	2.1k 1.5×	1.2k 1.0×	362 0.4×	156	5.8k
Thomas R. Korfhagen United States	55	6.3k 1.8×	2.3k 1.6×	931 0.7×	1.7k 1.4×	1.5k 1.6×	121	9.2k
Marc B. Hershenson United States	58	3.2k 0.9×	2.4k 1.6×	2.5k 1.8×	2.2k 1.9×	1.5k 1.6×	197	8.9k
Simone Rosseau Germany	37	1.4k 0.4×	1.2k 0.8×	621 0.4×	1.4k 1.2×	393 0.4×	94	5.0k
Mauricio Rojas Colombia	45	1.8k 0.5×	1.8k 1.2×	600 0.4×	2.0k 1.7×	1.3k 1.4×	154	7.0k
Gustavo Matute‐Bello United States	37	3.4k 1.0×	1.8k 1.2×	493 0.3×	2.2k 1.9×	608 0.7×	69	6.7k
Hong Wei Chu United States	43	2.8k 0.8×	1.3k 0.9×	3.0k 2.2×	2.0k 1.7×	598 0.7×	167	6.9k
Kent J. Johnson United States	46	1.7k 0.5×	1.3k 0.9×	434 0.3×	1.3k 1.1×	789 0.9×	135	5.8k
Charles W. Frevert United States	44	2.3k 0.7×	1.7k 1.1×	592 0.4×	2.4k 2.0×	538 0.6×	120	6.5k
Masayuki Ando Japan	42	2.8k 0.8×	1.6k 1.0×	1.5k 1.1×	645 0.5×	442 0.5×	170	6.3k

Countries citing papers authored by Mary Jane Thomassen

Since Specialization

Citations

This map shows the geographic impact of Mary Jane Thomassen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Jane Thomassen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Jane Thomassen more than expected).

Fields of papers citing papers by Mary Jane Thomassen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Jane Thomassen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Jane Thomassen. The network helps show where Mary Jane Thomassen may publish in the future.

Co-authorship network of co-authors of Mary Jane Thomassen

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Jane Thomassen. A scholar is included among the top collaborators of Mary Jane Thomassen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Jane Thomassen. Mary Jane Thomassen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Madenspacher, Jennifer H., Eric D. Morrell, Kymberly M. Gowdy, et al.. (2020). Cholesterol-25-hydroxylase promotes efferocytosis and resolution of lung inflammation. JCI Insight. 5(11). 55 indexed citations

Malur, Anagha, Arjun Mohan, Robert A. Barrington, et al.. (2019). Peroxisome Proliferator–Activated Receptor-γ Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis Model. American Journal of Respiratory Cell and Molecular Biology. 61(2). 198–208. 20 indexed citations

Malur, Anagha, Debra A. Tokarz, Kvin Lertpiriyapong, et al.. (2019). Alveolar Macrophage ABCG1 Deficiency Promotes Pulmonary Granulomatous Inflammation. American Journal of Respiratory Cell and Molecular Biology. 61(3). 332–340. 16 indexed citations

Hunt, Alan N., Anagha Malur, Pavlos G. Lagoudakis, et al.. (2017). Hepatic Steatosis Accompanies Pulmonary Alveolar Proteinosis. American Journal of Respiratory Cell and Molecular Biology. 57(4). 448–458. 10 indexed citations

Thomassen, Mary Jane, Catherine Demko, Jeffrey D. Klinger, & Robert C. Stern. (2015). Pseudomonas cepacia Colonization among Patients with Cystic Fibrosis. American Review of Respiratory Disease. 2 indexed citations

Barna, Barbara P., Anagha Malur, Michael B. Fessler, et al.. (2015). Elevated MicroRNA-33 in Sarcoidosis and a Carbon Nanotube Model of Chronic Granulomatous Disease. American Journal of Respiratory Cell and Molecular Biology. 54(6). 865–871. 29 indexed citations

Huizar, Isham, Anagha Malur, Cindy Kukoly, et al.. (2011). Novel Murine Model of Chronic Granulomatous Lung Inflammation Elicited by Carbon Nanotubes. American Journal of Respiratory Cell and Molecular Biology. 45(4). 858–866. 66 indexed citations

Malur, Anagha, Sergio Arce, Barbara P. Barna, et al.. (2009). Deletion of PPARγ in Alveolar Macrophages Is Associated with a Th-1 Pulmonary Inflammatory Response. The Journal of Immunology. 182(9). 5816–5822. 91 indexed citations

Barna, Barbara P., Ravinder Singh, Daniel A. Culver, et al.. (2009). DEFICIENCIES OF CATHELICIDIN AND VITAMIN D ACCOMPANY DISEASE SEVERITY IN SARCOIDOSIS. CHEST Journal. 136(4). 127S–127S. 3 indexed citations

10.

Malur, Achut G., et al.. (2008). Rituximab Depletes B-Lymphocytes and Improves Symptoms in Pulmonary Alveolar Proteinosis. Journal of Allergy and Clinical Immunology. 121(2). S225–S225. 2 indexed citations

11.

Thomassen, Mary Jane, Barbara P. Barna, Achut G. Malur, et al.. (2007). ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis. Journal of Lipid Research. 48(12). 2762–2768. 80 indexed citations

12.

Kobayashi, Michiko, Mary Jane Thomassen, Tracey L. Bonfield, et al.. (2005). An inverse relationship between peroxisome proliferator–activated receptor γ and allergic airway inflammation in an allergen challenge model. Annals of Allergy Asthma & Immunology. 95(5). 468–473. 34 indexed citations

13.

Venkateshiah, Saiprakash B., et al.. (2004). Recombinant Human Granulocyte Macrophage Colony Stimulating Factor (rhGM-CSF) therapy in Pulmonary Alveolar Proteinosis (PAP): An open label phase II clinical trial. CHEST Journal. 126(4). 755S–755S. 4 indexed citations

14.

Kavuru, Mani S., et al.. (2000). Exogenous Granulocyte–Macrophage Colony-Stimulating Factor Administration for Pulmonary Alveolar Proteinosis. American Journal of Respiratory and Critical Care Medicine. 161(4). 1143–1148. 119 indexed citations

15.

Wu, Weijia, Michael Samoszuk, Suzy Comhair, et al.. (2000). Eosinophils generate brominating oxidants in allergen-induced asthma. Journal of Clinical Investigation. 105(10). 1455–1463. 239 indexed citations

16.

Comhair, Suzy, Shuo Zheng, Raed A. Dweik, et al.. (2000). Molecular Mechanisms of Increased Nitric Oxide (NO) in Asthma: Evidence for Transcriptional and Post-Translational Regulation of NO Synthesis. The Journal of Immunology. 164(11). 5970–5980. 205 indexed citations

17.

Arroliga, Alejandro C., Raed A. Dweik, Suzy Comhair, et al.. (1998). Biochemical Reaction Products of Nitric Oxide as Quantitative Markers of Primary Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 158(3). 917–923. 178 indexed citations

18.

Thomassen, Mary Jane, et al.. (1994). Characterization of Exosurf (Surfactant)-Mediated Suppression of Stimulated Human Alveolar Macrophage Cytokine Responses. American Journal of Respiratory Cell and Molecular Biology. 10(4). 399–404. 77 indexed citations

19.

Thomassen, Mary Jane, David P. Meeker, Joyce Antal, Mary J. Connors, & Herbert Wiedemann. (1992). Synthetic Surfactant (Exosurf) Inhibits Endotoxin-stimulated Cytokine Secretion by Human Alveolar Macrophages. American Journal of Respiratory Cell and Molecular Biology. 7(3). 257–260. 87 indexed citations

20.

Thomassen, Mary Jane, Jeffrey D. Klinger, S J Badger, Daniel W. van Heeckeren, & Robert C. Stern. (1984). Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis. The Journal of Pediatrics. 104(3). 352–356. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact